Search

Your search keyword '"Shiaw-Pyng Wey"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Shiaw-Pyng Wey" Remove constraint Author: "Shiaw-Pyng Wey" Topic business.industry Remove constraint Topic: business.industry
43 results on '"Shiaw-Pyng Wey"'

Search Results

1. Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment

2. Investigation of reactive astrogliosis effect on post-stroke cognitive impairment

Catalog

Books, media, physical & digital resources

3. Visualization of ischemic stroke-related changes on 18F-THK-5351 positron emission tomography

4. Passivating Injured Endothelium with Kinexins in Thrombolytic Therapy

5. [18F]FP-(+)-DTBZ PET study in a lactacystin-treated rat model of Parkinson disease

6. Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects

7. Imaging characteristic of dual-phase 18F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer’s disease and mild cognitive impairment

8. Therapeutic effects of honokiol on motor impairment in hemiparkinsonian mice are associated with reversing neurodegeneration and targeting PPARγ regulation

9. Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion

10. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson’s disease patients

11. In Vivo Detection of Monoaminergic Degeneration in Early Parkinson Disease by 18F-9-Fluoropropyl-(+)-Dihydrotetrabenzazine PET

12. Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET

13. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging

14. P4‐338: Human Biodistribution and Radiation Dosimetry for the TAU Tracer 18 F‐THK‐5351

15. Amyloid deposition after cerebral hypoperfusion: Evidenced on [18F]AV-45 positron emission tomography

16. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([18F]AV-133) in a MPTP-lesioned PD mouse model

17. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements

18. Whole-Body Biodistribution and Radiation Dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): A Novel Vesicular Monoamine Transporter 2 Imaging Agent

19. Areca-nut extract modulates antigen-specific immunity and augments inflammation in ovalbumin-sensitized mice

20. Brain SPECT imaging and whole-body biodistribution with [123I]ADAM — a serotonin transporter radiotracer in healthy human subjects

21. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates

22. Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson?s disease

23. Clinical and [99mTc]TRODAT-1/[123I]IBZM SPECT Imaging Findings in Dopa-Responsive Dystonia

24. The correlation between cerebral hypoperfusion and amyloid plaque accumulation in patients with carotid artery stenosis evaluated by DUAL-PHASE 18F-AV-45 PET imaging

25. The optimal imaging time for [99Tcm]TRODAT-1/SPET in normal subjects and patients with Parkinsonʼs disease

26. Clinical acceptance of a molecular imaging agent: a long march with [99mTc]TRODAT

27. Treatment of chemotherapy-induced neutropenia in a rat model by using multiple daily doses of oral administration of G-CSF-containing nanoparticles

28. Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population

29. Amyloid plaque imaging from IMPY/SPECT to AV-45/PET

30. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies

31. Noninvasive monitoring of tumor growth in a rat glioma model: comparison between neurological assessment and animal imaging

32. GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain

33. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs

34. Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study

35. Simultaneous 99mTc and 123I dual-isotope brain striatal phantom single photon emission computed tomography: validation of 99mTc-TRODAT-1 and 123I-IBZM simultaneous dopamine system brain imaging

36. Quantitative micro-SPECT/CT for detecting focused ultrasound-induced blood-brain barrier opening in the rat

37. Areca nut extract suppresses T-cell activation and interferon-gamma production via the induction of oxidative stress

38. Imaging early-stage corticobasal degeneration with [99mTc]TRODAT-1 SPET

39. In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits

40. Dual SPECT of dopamine system using [99mTc]TRODAT-1 and [123I]IBZM in normal and 6-OHDA-lesioned formosan rock monkeys

41. The Detection of Nasopharynx Carcinoma in Technetium-99m (V) Dimercaptosuccinic Acid SPECT imaging

42. Correlation of early-phase 18F-florbetapir (AV-45/Amyvid) PET images to FDG images: preliminary studies: reply to Ballinger

43. The Study on the Formulation of a Tc(V)-99m-DMS Lyophilized Instant Kit for Tumor Scintigraphy